{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:11:20Z","timestamp":1778659880784,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["1061B04"],"award-info":[{"award-number":["1061B04"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["1081B28"],"award-info":[{"award-number":["1081B28"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["1082B03"],"award-info":[{"award-number":["1082B03"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["1071B17"],"award-info":[{"award-number":["1071B17"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["1071B16"],"award-info":[{"award-number":["1071B16"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014804","name":"Mackay Medical College","doi-asserted-by":"publisher","award":["1061B03"],"award-info":[{"award-number":["1061B03"]}],"id":[{"id":"10.13039\/501100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-MM-10814"],"award-info":[{"award-number":["MMH-MM-10814"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-MM-108-87"],"award-info":[{"award-number":["MMH-MM-108-87"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-MM-10705"],"award-info":[{"award-number":["MMH-MM-10705"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-MM-10608"],"award-info":[{"award-number":["MMH-MM-10608"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-MM-10714"],"award-info":[{"award-number":["MMH-MM-10714"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2320-B-214 -011 -MY3"],"award-info":[{"award-number":["108-2320-B-214 -011 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2320-B-715 -005"],"award-info":[{"award-number":["107-2320-B-715 -005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["105-2628-B-715-003-MY3"],"award-info":[{"award-number":["105-2628-B-715-003-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.neuropharm.2020.108269","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T11:14:15Z","timestamp":1597058055000},"page":"108269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray"],"prefix":"10.1016","volume":"178","author":[{"given":"Po-Sheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzer-Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Sheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsueh-Hsiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cheng","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108269_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2018.03.023","article-title":"The role of memantine in the treatment of major depressive disorder: clinical efficacy and mechanisms of action","volume":"827","author":"Amidfar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.neuroscience.2011.05.001","article-title":"Positive emotional learning is regulated in the medial prefrontal cortex by GluN2B-containing NMDA receptors","volume":"192","author":"Burgdorf","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108269_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2015.07.039","article-title":"Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats","volume":"294","author":"Burgdorf","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108269_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2015.09.004","article-title":"The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus","volume":"308","author":"Burgdorf","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108269_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S146114570999112X","article-title":"Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: the role of 5-HT and GABA","volume":"13","author":"Casarotto","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.euroneuro.2015.03.004","article-title":"BDNF-TRKB signaling system of the dorsal periaqueductal gray matter is implicated in the panicolytic-like effect of antidepressant drugs","volume":"25","author":"Casarotto","year":"2015","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108269_bib8","doi-asserted-by":"crossref","first-page":"108068","DOI":"10.1016\/j.neuropharm.2020.108068","article-title":"Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions","volume":"170","author":"Chou","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.06.033","article-title":"(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","volume":"139","author":"Chou","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/mp.2016.34","article-title":"Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects","volume":"22","author":"Chowdhury","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archpsyc.57.1.21","article-title":"Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model","volume":"57","author":"Cyranowski","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ijnp\/pyy101","article-title":"Positive N-Methyl-D-Aspartate receptor modulation by rapastinel promotes rapid and sustained antidepressant-like effects","volume":"22","author":"Donello","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2020.108269_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0033291712001511","article-title":"Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature","volume":"43","author":"Ferrari","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2020.108269_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1073\/pnas.1814709116","article-title":"Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine","volume":"116","author":"Fukumoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108269_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neuropharm.2020.108269_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269881118812095","article-title":"Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine","volume":"33","author":"Highland","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib18","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1523\/JNEUROSCI.5583-12.2013","article-title":"Hypofunction of glutamatergic neurotransmission in the periaqueductal gray contributes to nerve-injury-induced neuropathic pain","volume":"33","author":"Ho","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib19","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1113\/JP270384","article-title":"Impairment of adenylyl cyclase-mediated glutamatergic synaptic plasticity in the periaqueductal grey in a rat model of neuropathic pain","volume":"593","author":"Ho","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib20","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1523\/JNEUROSCI.2671-11.2011","article-title":"Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition","volume":"31","author":"Ho","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/npp.2017.199","article-title":"Periaqueductal gray glutamatergic transmission governs chronic stress-induced depression","volume":"43","author":"Ho","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2015.17.2\/dionescu","article-title":"Pharmacological approaches to the challenge of treatment-resistant depression","volume":"17","author":"Ionescu","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib23","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1523\/JNEUROSCI.1185-16.2016","article-title":"A basal forebrain site coordinates the modulation of endocrine and behavioral stress responses via divergent neural pathways","volume":"36","author":"Johnson","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib24","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/mp.2017.220","article-title":"BDNF release and signaling are required for the antidepressant actions of GLYX-13","volume":"23","author":"Kato","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.psych.48.1.191","article-title":"The effects of stressful life events on depression","volume":"48","author":"Kessler","year":"1997","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2016.09.011","article-title":"Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures","volume":"111","author":"Lepack","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108269_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/npp.2016.202","article-title":"GLYX-13 produces rapid antidepressant responses with key synaptic and behavioral effects distinct from ketamine","volume":"42","author":"Liu","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(01)00194-5","article-title":"Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons","volume":"29","author":"Lu","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108269_bib30","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1523\/JNEUROSCI.4761-11.2011","article-title":"Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3","volume":"31","author":"Ma","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.12.001","article-title":"New targets for rapid antidepressant action","volume":"152","author":"Machado-Vieira","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopsych.2009.10.018","article-title":"The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents","volume":"67","author":"Malkesman","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.1144298","article-title":"When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans","volume":"317","author":"Mobbs","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108269_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/13543784.2014.852536","article-title":"GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists","volume":"23","author":"Moskal","year":"2014","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2020.108269_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X14666160321122703","article-title":"The development of rapastinel (formerly GLYX-13); A rapid acting and long lasting antidepressant","volume":"15","author":"Moskal","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neuropharm.2005.06.006","article-title":"GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator","volume":"49","author":"Moskal","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108269_bib39","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s40473-015-0050-5","article-title":"Novel glutamatergic treatments for severe mood disorders","volume":"2","author":"Park","year":"2015","journal-title":"Curr Behav Neurosci Rep"},{"key":"10.1016\/j.neuropharm.2020.108269_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.pra.0000462606.17725.93","article-title":"Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent","volume":"21","author":"Preskorn","year":"2015","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.neuropharm.2020.108269_bib42","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.284.5421.1811","article-title":"Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation","volume":"284","author":"Shi","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108269_bib43","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108269_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108269_bib45","first-page":"E4726","article-title":"Depression-like behavior in rat: involvement of galanin receptor subtype 1 in the ventral periaqueductal gray","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108269_bib46","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s00213-016-4399-2","article-title":"Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression","volume":"233","author":"Yang","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108269_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2018.11.012","article-title":"Transcranial direct current stimulation induces hippocampal metaplasticity mediated by brain-derived neurotrophic factor","volume":"144","author":"Yu","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108269_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","article-title":"Convergent mechanisms underlying rapid antidepressant action","volume":"32","author":"Zanos","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2020.108269_bib49","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108269_bib51","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.neuropharm.2008.08.018","article-title":"A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus","volume":"55","author":"Zhang","year":"2008","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:40:00Z","timestamp":1778658000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"alternative-id":["S0028390820303373"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108269","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108269"}}